Sanjay Singh Biography and Net Worth

CRO of Royalty Pharma

Sanjay Singh is the CRO of Royalty Pharma.

What is Sanjay Kumar Singh's net worth?: The estimated net worth of Sanjay Kumar Singh is at least $3.56 million as of April 4th, 2022. Singh owns 134,555 shares of Royalty Pharma stock worth more than $3,556,289 as of November 23rd. This net worth estimate does not reflect any other investments that Singh may own. Learn More about Sanjay Kumar Singh's net worth.
How do I contact Sanjay Kumar Singh?: The corporate mailing address for Singh and other Royalty Pharma executives is 110 E 59th Street, New York NY, 10022. Royalty Pharma can also be reached via phone at 212-883-0200 and via email at [email protected]. Learn More on Sanjay Kumar Singh's contact information.
Has Sanjay Kumar Singh been buying or selling shares of Royalty Pharma?: Sanjay Kumar Singh has not been actively trading shares of Royalty Pharma in the last ninety days. Learn More on Sanjay Kumar Singh's trading history.
Who are Royalty Pharma's active insiders?: Royalty Pharma's insider roster includes Terrance Coyne (CFO), Henry Fernandez (Director), William Ford (Director), Mario Giuliani (Director), Pablo Legorreta (Founder & Chief Executive Officer and Chairman), George Lloyd (EVP), James Reddoch (EVP), Rory Riggs (Director), Sanjay Singh (CRO), and Marshall Urist (EVP). Learn More on Royalty Pharma's active insiders.
Are insiders buying or selling shares of Royalty Pharma?: In the last twelve months, insiders at the biopharmaceutical company sold shares 3 times. They sold a total of 312,631 shares worth more than $8,860,323.39. The most recent insider tranaction occured on January, 4th when Director Rory B Riggs sold 35,702 shares worth more than $983,590.10. Insiders at Royalty Pharma own 18.9% of the company. Learn More about insider trades at Royalty Pharma.
Information on this page was last updated on 1/4/2024.

Sanjay Kumar Singh Insider Trading History at Royalty Pharma

Sanjay Kumar Singh Buying and Selling Activity at Royalty Pharma

Royalty Pharma Company Overview

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Today's Range

Now: $26.43

$26.33

$26.63

50 Day Range

MA: $27.30

$25.58

$28.38

2 Week Range

Now: $26.43

$25.10

$31.66

Volume

2,461,717 shs

Average Volume

2,633,763 shs

Market Capitalization

$15.57 billion

P/E Ratio

13.69

Dividend Yield

3.20%

Beta

0.47

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.